The comorbidity of depression and substance use disorders.

By J. Swendsen, Kathleen R. Merikangas. Clinical Psychology Review, 2000

627 citations recorded by the source corpus.

Subfields: Epidemiology, Experimental and Cognitive Psychology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/259d9fc72682bf1623972ecacc62760f57403bf8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. B. Grant
2. D. Hasin
3. F. Stinson
4. W. Compton
5. Y. Thomas
6. David Goldman
7. Elizabeth L. Ogburn
8. G. Oroszi

In Experimental and Cognitive Psychology

1. Ronald C. Kessler
2. B. Grant
3. N. Sampson
4. F. Stinson
5. R. Jin
6. D. Hasin
7. W. Compton
8. Y. Thomas

In Pathology and Forensic Medicine

1. B. Grant
2. D. Hasin
3. F. Stinson
4. W. Compton
5. Y. Thomas
6. David Goldman
7. Elizabeth L. Ogburn
8. G. Oroszi

Citations in the corpus

• Self-esteem in a broad-spectrum approach for mental health promotion. (2004, background): “There is a significant degree of co-morbidity between and within internalizing and externalizing problem behaviors such as depression, anxiety, substance disorders and delinquency (Harrington et al., 1996; Angold et al., 1999; Swendsen and Merikangas, 2000).”
• Mental Disorders as Risk factors for Substance Use, Abuse and Dependence: Results from the 10-year Follow-up of the National Comorbidity Survey (2010, background): “The reasons for these associations have been debated widely [21–24], including the possibility that they may result in part from causal effects of primary mental disorders.”
• Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. (2015, background): “, 2004) and lifetime alcohol abuse NCS) (Swendsen and Merikangas, 2000) and one study from Puerto ico (Swendsen et al.”
• The genetics of addictions: uncovering the genes (2005, background): “Such aggregation can be due to the natural course of one disease increasing the risk of developing a second disease or because individuals who are chronic, treatment resistant or psychosocially impaired are more likely to be ascertaine”
• Victimization and Substance Abuse among Women: Contributing Factors, Interventions, and Implications (2002, background): “Swendsen and Merikangas (2000) reviewed the literature and found that individuals who have substance abuse problems also tend to meet criteria for depression, and vice versa.”
• Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. (2007, background): “Second, accurate information on the distinct comorbidity of alcohol abuse and dependence with other specific mental disorders is important.(28,29) These aspects require larger samples than were previously available.”
• Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. (2003, background): “Indeed, as we emphasize throughout the article, mechanisms and causal processes underlying comorbidity (e.g., smokers are more depressed than nonsmokers) ultimately can only be tested through within-subject approaches (Swendsen & Merikangas, 2000).”
• Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. (2007, positive): “Axis I and II comorbidity with drug use disorders has been associated with underachievement, decreased work productivity, poor health, neuropsychological impairment, human immunodeficiency virus infection, hepatitis, social dysfunction, violence, incarceration, poverty, homelessness, a lower probabi”